Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling

被引:28
|
作者
Tong, Angie [1 ]
Kelly, Scott [1 ]
Nusbaum, Rachel [1 ]
Graves, Kristi [1 ]
Peshkin, Beth N. [1 ]
Valdimarsdottir, Heiddis B. [2 ]
Wood, Marie [3 ]
McKinnon, Wendy [3 ]
Garber, Judy [4 ]
McCormick, Shelley R. [4 ]
Jandorf, Lina [2 ]
Schwartz, Marc D. [1 ]
机构
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] MSSM, New York, NY USA
[3] Univ Vermont, Coll Med, Familial Canc Program, Vermont Canc Ctr, Burlington, VT USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
BRCA1; BRCA2; cancer; genetic counseling; risk-reducing mastectomy; risk-reducing oophorectomy; oncology; BREAST-CANCER RISK; CONTRALATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; OVARIAN-CANCER; SALPINGO-OOPHORECTOMY; BILATERAL MASTECTOMY; DECISIONAL CONFLICT; HEREDITARY BREAST; RANDOMIZED-TRIAL; FAMILY-HISTORY;
D O I
10.1002/pon.3560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveGenetic testing for breast and ovarian cancer susceptibility is now part of routine clinical practice. Although rates of risk-reducing surgery following genetic testing have been increasing, little is known about attitudes toward risk-reducing surgery in women prior to genetic counseling and testing. This study examines correlates of patient intentions to undergo risk-reducing mastectomy (RRM) and risk-reducing oophorectomy (RRO). MethodsParticipants were 696 women, ages 21-85, who sought breast cancer gene 1 and 2 (BRCA1/2) genetic counseling and had at least a 10% risk of carrying a mutation. The sample included women who were affected with breast or ovarian cancer and unaffected women with a known familial BRCA1/2 mutation. Participants completed a precounseling telephone questionnaire. ResultsPrior to receiving genetic counseling, 23.3% of participants were considering RRM and 42.5% were considering RRO. Variables that were independently associated with RRM intentions were cancer-specific distress (OR=1.14, 95% CI=1.03-1.26), perceived risk of breast cancer (OR=1.16, 95% CI=1.05-1.28), education (OR=1.76, 95% CI=1.03-2.99), and age (OR=0.96, 95% CI=0.95-0.98). Predictors of RRO intentions were perceived risk for ovarian cancer (OR=1.25, 95% CI=1.14-1.37), perceived risk of carrying a BRCA1/2 mutation (OR=1.74, 95% CI=1.15-2.62), marital status (OR=1.92, 95% CI=1.34-2.76), and age (OR=1.02, 95% CI=1.00-1.03). ConclusionsBecause precounseling intentions predict subsequent risk-reducing surgery decisions, this study identified patient factors associated with surgical intentions. These factors reinforce the critical role for pretest genetic counseling in communicating accurate risk estimates and management options, and addressing psychosocial concerns, to facilitate informed decision making regarding RRM and RRO. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [1] Hysterectomy as a risk-reducing procedure in BRCA1 and BRCA2 women.
    Pina, Ana Teresa
    Fragoso, Ana Sofia
    Lopez, Berta
    Miguel, Isalia
    Bento, Sandra
    Mira, Beatriz
    Duarte, Teresa
    Santos, Sidonia
    Luis, Ana Carla
    Vaz, Fatima H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Risk-reducing mastectomy and breast reconstruction for BRCA1, BRCA2 carriers and high-risk women and role of acellular dermal matrices in reducing the risk of revision surgery
    Valassiadou, K.
    Lambert, K.
    Desai, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S145 - S145
  • [3] Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers
    Laitman, Y.
    Vaisman, Y.
    Feldman, D.
    Helpman, L.
    Gitly, M.
    Shimon, S. Paluch
    Berger, R.
    Cohen, L.
    Narod, S. A.
    Friedman, E.
    CLINICAL GENETICS, 2014, 85 (01) : 68 - 71
  • [4] Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
    Domchek, Susan M.
    Friebel, Tara M.
    Singer, Christian F.
    Evans, D. Gareth
    Lynch, Henry T.
    Isaacs, Claudine
    Garber, Judy E.
    Neuhausen, Susan L.
    Matloff, Ellen
    Eeles, Rosalind
    Pichert, Gabriella
    Van T'veer, Laura
    Tung, Nadine
    Weitzel, Jeffrey N.
    Couch, Fergus J.
    Rubinstein, Wendy S.
    Ganz, Patricia A.
    Daly, Mary B.
    Olopade, Olufunmilayo I.
    Tomlinson, Gail
    Schildkraut, Joellen
    Blum, Joanne L.
    Rebbeck, Timothy R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (09): : 967 - 975
  • [5] Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?
    Manoukian, Siranoush
    Alfieri, Sara
    Bianchi, Elisabetta
    Peissel, Bernard
    Azzollini, Jacopo
    Borreani, Claudia
    PSYCHO-ONCOLOGY, 2019, 28 (09) : 1871 - 1878
  • [6] Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations
    Kauff, ND
    Scheuer, L
    Robson, ME
    Glogowski, E
    Kelly, B
    Barakat, R
    Heerdt, A
    Borgen, PI
    Davis, JG
    Offit, K
    GENETICS IN MEDICINE, 2001, 3 (06) : 422 - 425
  • [7] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff, ND
    Satagopan, JM
    Robson, ME
    Scheuer, L
    Hensley, M
    Hudis, CA
    Ellis, NA
    Boyd, J
    Borgen, PI
    Barakat, RR
    Norton, L
    Offit, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21): : 1609 - 1615
  • [8] Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
    B. E. Kiely
    M. L. Friedlander
    R. L. Milne
    L. Stanhope
    P. Russell
    M. A. Jenkins
    P. Weideman
    S. A. McLachlan
    P. Grant
    J. L. Hopper
    K. A. Phillips
    Familial Cancer, 2011, 10 : 505 - 514
  • [9] Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer
    Kiely, B. E.
    Friedlander, M. L.
    Milne, R. L.
    Stanhope, L.
    Russell, P.
    Jenkins, M. A.
    Weideman, P.
    McLachlan, S. A.
    Grant, P.
    Hopper, J. L.
    Phillips, K. A.
    FAMILIAL CANCER, 2011, 10 (03) : 505 - 514
  • [10] Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers A Complex Discussion
    Domchek, Susan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (01): : 27 - 28